EdgarLookup
SC 13D/A

AMENDMENT NO. 5 TO SCHEDULE 13D

Company
Altamira Therapeutics Ltd.
Filed
August 20, 2020
Accession Number
0001213900-20-023100
View Document ↗ View on SEC.gov ↗